{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:18:27Z","timestamp":1783138707919,"version":"3.54.6"},"reference-count":25,"publisher":"Japan Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej25-0651","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T22:10:26Z","timestamp":1775513426000},"page":"837-846","source":"Crossref","is-referenced-by-count":0,"title":["Early predictors of 6-month thyroid-stimulating antibody levels after radioactive iodine therapy for Graves\u2019 disease: implications for pregnancy planning"],"prefix":"10.1507","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4154-500X","authenticated-orcid":false,"given":"Seigo","family":"Tachibana","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Yamashita Thyroid Hospital, Fukuoka 812-0034, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5058-9349","authenticated-orcid":false,"given":"Yuji","family":"Nagayama","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Yamashita Thyroid Hospital, Fukuoka 812-0034, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5846-8748","authenticated-orcid":false,"given":"Takashi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Yamashita Thyroid Hospital, Fukuoka 812-0034, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3570-3561","authenticated-orcid":false,"given":"Yusuke","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Yamashita Thyroid Hospital, Fukuoka 812-0034, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9802-3697","authenticated-orcid":false,"given":"Daisuke","family":"Tatsushima","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yamashita Thyroid Hospital, Fukuoka 812-0034, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4297-134X","authenticated-orcid":false,"given":"Yusuke","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yamashita Thyroid Hospital, Fukuoka 812-0034, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1424-620X","authenticated-orcid":false,"given":"Hisakazu","family":"Shindo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yamashita Thyroid Hospital, Fukuoka 812-0034, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0410-1399","authenticated-orcid":false,"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yamashita Thyroid Hospital, Fukuoka 812-0034, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0761-6209","authenticated-orcid":false,"given":"Shinya","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yamashita Thyroid Hospital, Fukuoka 812-0034, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0805-8886","authenticated-orcid":false,"given":"Hiroyuki","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yamashita Thyroid Hospital, Fukuoka 812-0034, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","unstructured":"1 Japan Thryoid Association (2019) Guidelines for the Treatment of Graves\u2019 Diesase 2019. Nankodo, Tokyo, Japan (in Japanese)."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, et al. (2016) 2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26: 1343\u20131421.","DOI":"10.1089\/thy.2016.0229"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3 Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, et al. (2017) 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27: 315\u2013389.","DOI":"10.1089\/thy.2016.0457"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, et al. (2018) 2018 European Thyroid Association Guideline for the management of Graves\u2019 hyperthyroidism. Eur Thyroid J 7: 167\u2013186.","DOI":"10.1159\/000490384"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Lindgren O, Asp P, Sundl\u00f6v A, Tennvall J, Shahida B, et al. (2019) The effect of radioiodine treatment on TRAb, anti-TPO, and anti-TG in Graves\u2019 disease. Eur Thyroid J 8: 64\u201369.","DOI":"10.1159\/000495504"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, et al. (2021) The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur J Endocrinol 185: G43\u2013G67.","DOI":"10.1530\/EJE-21-0861"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Jankovski L, Grosek \u0160, \u017derjav MT, \u0160imic MV, Zaletel K (2024) Neonatal thyrotoxicosis in infants of mothers with Graves\u2019 disease treated for radioiodine-induced hypothyroidism: a literature review. Children (Basel) 11: 968.","DOI":"10.3390\/children11080968"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Dietlein M, Schmidt M, Drzezga A, Kobe C (2025) Radioiodine therapy of Graves\u2019 disease in women with childbearing potential and the pre-conceptional counseling about antithyroid drugs. J Clin Med 14: 1667.","DOI":"10.3390\/jcm14051667"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Bucci I, Giuliani C, Napolitano G (2017) Thyroid-stimulating hormone receptor antibodies in pregnancy: clinical relevance. Front Endocrinol (Lausanne) 8: 137.","DOI":"10.3389\/fendo.2017.00137"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Soto J, Weissglas B, von Plessing-Pierry G, Del Solar MP, Pe\u00f1a-Villa C, et al. (2024) Fetal hyperthyroidism secondary to maternal basedow-Graves\u2019 disease. AJP Rep 14: e176\u2013e183.","DOI":"10.1055\/a-2317-9431"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Donnelly MA, Wood C, Casey B, Hobbins J, Barbour LA (2015) Early severe fetal Graves disease in a mother after thyroid ablation and thyroidectomy. Obstet Gynecol 125: 1059\u20131062.","DOI":"10.1097\/AOG.0000000000000582"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12 Kubota S, Ohye H, Sasaki I, Nishihara E, Kudo T, et al. (2005) Successful use of iodine and levothyroxine to treat Graves\u2019 disease in a pregnant patient with allergy to antithyroid drugs and high thyrotropin-binding inhibitor immunoglobulin after radioiodine therapy. Thyroid 15: 1373\u20131376.","DOI":"10.1089\/thy.2005.15.1373"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Peleg D, Cada S, Peleg A, Ben-Ami M (2002) The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol 99: 1040\u20131043.","DOI":"10.1097\/00006250-200206000-00016"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Abeillon-du Payrat J, Chikh K, Bossard N, Bretones P, Gaucherand P, et al. (2014) Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism. Eur J Endocrinol 171: 451\u2013460.","DOI":"10.1530\/EJE-14-0254"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Hosoda A, Arata N, Umehara N, Sato S, Sankoda A, et al. (2025) Prediction of fetal Graves\u2019 disease among pregnant women with Graves\u2019 disease who have undergone thyroidectomy or radioactive iodine therapy: A retrospective observational study. Endocr J 72: 819\u2013829.","DOI":"10.1507\/endocrj.EJ24-0434"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Brott DA, Goodman MJ, Hermann RP, Merz M, Calvo R, et al. (2018) Are laboratory parameter (biomarker) values similar to the healthy volunteer reference range in all patient populations? Drug Des Devel Ther 12: 2757\u20132773.","DOI":"10.2147\/DDDT.S173671"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Nelson HA, Doyle K, Straseski JA (2025) TSH receptor antibody test utilization patterns from a national reference laboratory: TRAb, TSI, or both? J Clin Endocrinol Metab 111: e92\u2013e99.","DOI":"10.1210\/clinem\/dgaf330"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Brown MC, Spencer R (1978) Thyroid gland volume estimated by use of ultrasound in addition to scintigraphy. Acta Radiol Oncol Radiat Phys Biol 17: 337\u2013341.","DOI":"10.3109\/02841867809127937"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Imseis RE, Vanmiddlesworth L, Massie JD, Bush AJ, Vanmiddlesworth NR (1998) Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 83: 685\u2013687.","DOI":"10.1210\/jcem.83.2.4538"},{"key":"20","unstructured":"20 Japan Radiological Society, Japanese Society of Nuclear Medicine, Japan Society of Nuclear Medicine Technology, Japan Thyroid Association, The Japan Endocrine Society, et al. (2018) Manual for the Appropriate Use of Radioactive Iodine (I-131) Sodium Capsules in Internal Therapy (4th). Tokyo, Japan. https:\/\/oncology.jsnm.org\/i-131\/2018\/05-17 accessed on December 11, 2025 (in Japanese)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48: 452\u2013458.","DOI":"10.1038\/bmt.2012.244"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Nakatake N, Fukata S, Tajiri J (2011) Prediction of post-treatment hypothyroidism using changes in thyroid volume after radioactive iodine therapy in adolescent patients with Graves\u2019 disease. Int J Pediatr Endocrinol 2011: 14.","DOI":"10.1186\/1687-9856-2011-14"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Cooper DS (2005) Antithyroid drugs. N Engl J Med 352: 905\u2013917.","DOI":"10.1056\/NEJMra042972"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24 Calissendorff J, Falhammar H (2017) Lugol\u2019s solution and other iodide preparations: perspectives and research directions in Graves\u2019 disease. Endocrine 58: 467\u2013473.","DOI":"10.1007\/s12020-017-1461-8"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Chiovato L, Fiore E, Vitti P, Rocchi R, Rago T, et al. (1998) Outcome of thyroid function in Graves\u2019 patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. J Clin Endocrinol Metab 83: 40\u201346.","DOI":"10.1210\/jc.83.1.40"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/7\/73_EJ25-0651\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:41:59Z","timestamp":1783136519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/7\/73_EJ25-0651\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0651","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ25-0651"}}